Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Sotac Pharmaceuticals Ltd
Score 48/100• Decent
Sotac Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks and market sentiment.
Company’s Health89/100
Valuation 60/100 · PB 2.3643
Technical Avoid
1M 1.543% 6M 0.321% 1Y -13.194%
Confidence100%
No promoter pledgeReasonable PB valuation
Thin margins
#151
View details ➜
W
Welcure Drugs and Pharmaceuticals Ltd
Score 48/100• Risky
The stock shows potential in a growing sector but faces significant risks and inconsistencies in performance metrics.
Company’s Health45/100
Valuation 100/100 · PB 0.6642
Technical Avoid
1M -40.854% 6M -35.873% 1Y -21.196%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROE
#152
View details ➜
W
Wardwizard Healthcare Ltd
Score 48/100• Risky
Wardwizard Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health75/100
Valuation 100/100 · PB -0.2941
Technical Momentum
1M — 6M 88.155% 1Y 97.513%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#153
View details ➜
W
Wanbury Ltd
Score 48/100• Risky
Wanbury Ltd presents several risks with limited growth prospects and high valuation metrics, making it a risky investment at this time.
Company’s Health42/100
Valuation 20/100 · PB 14.1962
Technical Avoid
1M -5.553% 6M -5.05% 1Y -2.996%
Confidence100%
High debt/equityPromoter pledge present
#154
View details ➜
U
Unjha Formulations Ltd
Score 48/100• Decent
Unjha Formulations Ltd shows potential but faces challenges in execution and market sentiment.
Company’s Health61/100
Valuation 40/100 · PB 3.5002
Technical Avoid
1M -3.307% 6M 13.303% 1Y -25.213%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#155
View details ➜
S
Sunil Healthcare Ltd
Score 48/100• Risky
Sunil Healthcare Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health45/100
Valuation 80/100 · PB 1.1652
Technical Avoid
1M -2.5% 6M 8.945% 1Y -9.571%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#156
View details ➜
S
Soni Medicare Ltd
Score 48/100• Risky
Soni Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health51/100
Valuation 20/100 · PB 33.3919
Technical Avoid
1M -4.419% 6M 92.052% 1Y 250.087%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#157
View details ➜
K
Kwality Pharmaceuticals Ltd
Score 48/100• Risky
Kwality Pharmaceuticals Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.
Company’s Health90/100
Valuation 40/100 · PB 3.398
Technical Avoid
1M -9.605% 6M 4.946% 1Y 5.721%
Confidence100%
Low leverage (D/E)No promoter pledge
#158
View details ➜
Z
Zota Health Care Ltd
Score 48/100• Risky
Zota Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health63/100
Valuation 20/100 · PB 20.3876
Technical Avoid
1M -2.641% 6M 79.112% 1Y 143.609%
Confidence100%
Decent revenue growth
Weak ROEPromoter pledge present
#159
View details ➜
W
Wockhardt Ltd
Score 48/100• Risky
Wockhardt Ltd presents several risks, particularly in growth consistency and balance sheet strength, making it a risky investment at this time.
Company’s Health30/100
Valuation 40/100 · PB 4.7286
Technical Avoid
1M -10.151% 6M -3.359% 1Y 25.412%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#160
View details ➜
V
Vivo Bio Tech Ltd
Score 48/100• Risky
Vivo Bio Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health58/100
Valuation 80/100 · PB 1.052
Technical Avoid
1M -0.7% 6M 3.924% 1Y 0.816%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROE
#161
View details ➜
V
Vivanza Biosciences Ltd
Score 48/100• Risky
Vivanza Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health26/100
Valuation 60/100 · PB 2.0202
Technical Avoid
1M -0.99% 6M -11.111% 1Y -46.95%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#162
View details ➜
V
Vaidya Sane Ayurved Laboratories Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health79/100
Valuation 40/100 · PB 4.9026
Technical Avoid
1M -6.217% 6M 135.438% 1Y 91.218%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#163
View details ➜
U
Unichem Laboratories Ltd
Score 48/100• Decent
Unichem Laboratories has a decent score, indicating potential but with notable risks and inconsistencies in growth and profitability.
Company’s Health68/100
Valuation 80/100 · PB 1.365
Technical Avoid
1M -7.06% 6M -22.128% 1Y -36.335%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#164
View details ➜
S
Sandu Pharmaceuticals Ltd
Score 48/100• Decent
Sandu Pharmaceuticals has a decent growth outlook but faces challenges in valuation and execution risks.
Company’s Health70/100
Valuation 80/100 · PB 1.0137
Technical Avoid
1M -6.454% 6M -10.204% 1Y -25.949%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#165
View details ➜
Showing 151 to 165 of 260 (18 Pages)